Literature DB >> 18438630

[Three-dimensional imaging in central serous chorioretinopathy].

G Stock1, C Ahlers, R Sayegh, M Ritter, S Kolar, I Golbaz, U Schmidt-Erfurth.   

Abstract

BACKGROUND: Conventional optical coherence tomography (OCT) has brought new insights to retinal diagnostics, but it is restricted due to its low scanning speed and limited resolution. In this study, high-resolution raster scanning OCT (HR-OCT) was used to identify typical changes in central serous chorioretinopathy (CSC).
METHODS: Fifteen consecutive patients with acute CSC were imaged using HR-OCT with an axial image resolution of 6 mum. The scanned area measured 6x6 mm2. Three-dimensional (3D) evaluation was performed using various analysing programmes.
RESULTS: Topographic changes in CSC could be visualised with 3D reconstructions in all locations. Retinal thickness was measured with the automatic segmentation mode and quantified precisely. Results were presented in 2D and 3D maps. En-face imaging as a modality to present an integrative overview showed specific alterations in CSC.
CONCLUSION: HR-OCT was able to provide essential additional information about CSC when combined with appropriate analysing programmes, allowing the identification of typical differences. Aside from precise volumetric measurements, exact localisation of pathological deviations could be achieved.

Entities:  

Mesh:

Year:  2008        PMID: 18438630     DOI: 10.1007/s00347-008-1741-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  29 in total

1.  Evaluation of central serous chorioretinopathy with optical coherence tomography.

Authors:  T Iida; N Hagimura; T Sato; S Kishi
Journal:  Am J Ophthalmol       Date:  2000-01       Impact factor: 5.258

2.  Selective retina therapy in patients with central serous chorioretinopathy.

Authors:  H Elsner; E Pörksen; C Klatt; A Bunse; D Theisen-Kunde; R Brinkmann; R Birngruber; H Laqua; J Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

3.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.

Authors:  Felice Cardillo Piccolino; Roberta Rigault de la Longrais; Giambattista Ravera; Chiara M Eandi; Luca Ventre; Ali' Abdollahi; Marilisa Manea
Journal:  Am J Ophthalmol       Date:  2005-01       Impact factor: 5.258

4.  Alterations of retinal pigment epithelium in central serous chorioretinopathy.

Authors:  Yasuhiko Hirami; Akitaka Tsujikawa; Manabu Sasahara; Norimoto Gotoh; Hiroshi Tamura; Atsushi Otani; Michiko Mandai; Nagahisa Yoshimura
Journal:  Clin Exp Ophthalmol       Date:  2007-04       Impact factor: 4.207

5.  Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy.

Authors:  Keiichi Mitarai; Fumi Gomi; Yasuo Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-05       Impact factor: 3.117

6.  Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.

Authors:  T Y Y Lai; W-M Chan; H Li; R Y K Lai; D T L Liu; D S C Lam
Journal:  Br J Ophthalmol       Date:  2006-04-05       Impact factor: 4.638

7.  Central serous chorioretinopathy in younger and older adults.

Authors:  R F Spaide; L Campeas; A Haas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

8.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

Review 9.  Type-A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Retina       Date:  1987       Impact factor: 4.256

10.  Indocyanine green angiographic findings in central serous chorioretinopathy.

Authors:  C Prünte
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

View more
  5 in total

1.  [Specific alterations in the retinal microstructure in neovascular age-related macular degeneration under anti-VEGF therapy. A detailed analysis of intraretinal changes and their possible role for follow-up].

Authors:  T Schneiderbauer; C Ahlers; G Stock; I Golbaz; C Schütze; S Sacu; U Schmidt-Erfurth
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

2.  Three-dimensional imaging by spectral domain optical coherence tomography in central serous chorioretinopathy with fibrin.

Authors:  Sandeep Saxena; Neha Sinha; Shashi Sharma
Journal:  J Ocul Biol Dis Infor       Date:  2012-05-22

3.  [Spectral domain OCT in central serous chorioretinopathy: description of retinal changes].

Authors:  V Valet; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2012-09       Impact factor: 1.059

4.  Topographic assessment of retinal pigment epithelium detachment in central serous chorioretinopathy by three-dimensional optical coherence tomography single-layer retinal pigment epithelium map.

Authors:  Sandeep Saxena; Carsten H Meyer; Shashi R Sharma
Journal:  J Ocul Biol Dis Infor       Date:  2013-01-31

Review 5.  Characteristics of intraretinal deposits in acute central serous chorioretinopathy.

Authors:  Andrea M Plateroti; Matthew T Witmer; Szilárd Kiss; Donald J D'Amico
Journal:  Clin Ophthalmol       Date:  2014-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.